Finally, in experiments from our own laboratory, we analyzed the binding ability of transcripts over 200 nucleotides in size to SUZ12, one of the PRC2 complex components, in prostate cancer cells [183]. This evidence concerns the gene SUZ12 and prostate carcinoma.